Anna W. K.
- Country
- Poland
- Department
- NA
Research Overview
- Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Duvakitug for Induction Therapy in Moderately to Severely Active Crohn's Disease
- Efficacy and Safety of Duvakitug for Maintenance Therapy in Participants with Moderately to Severely Active Crohn’s Disease: A Phase 3, Randomized, Placebo-Controlled Study
- Phase II Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of Vixarelimab in Patients with Moderate to Severe Ulcerative Colitis
Data & Insights
Has run more than one trial at 461 of 672 partner sites.
Specializations
Inflammatory Bowel Disease Management
This investigator specializes in treating complex gastrointestinal conditions, with particular emphasis on inflammatory bowel disease (IBD). Their research encompasses both Crohn's disease and ulcerative colitis, focusing on innovative therapeutic approaches.
- Moderate to severe Crohn's disease interventions
- Ulcerative colitis treatment strategies
- Long-term disease management
Novel Therapeutic Applications
The investigator explores advanced treatment options including biological therapies and combination therapeutic approaches. Their work involves evaluating new compounds for gastrointestinal conditions and investigating treatment responses in various patient populations.
- Biological therapy assessment
- Combination treatment strategies
- Treatment response evaluation
Specialized Gastrointestinal Research
Their expertise extends to various gastrointestinal disorders, including celiac disease. The investigator studies specific symptoms such as bowel urgency and their management in inflammatory conditions.
- Celiac disease interventions
- Symptom-specific treatments
- Clinical response assessment
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.